AIxCrypto Holdings Files 8-K with Financials
Ticker: AIXC · Form: 8-K · Filed: Nov 21, 2025 · CIK: 1460702
| Field | Detail |
|---|---|
| Company | Aixcrypto Holdings, INC. (AIXC) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, corporate-update
TL;DR
AIxCrypto Holdings (fka Qualigen) filed an 8-K on Nov 21, 2025, covering events from Nov 20, 2025. Financials and other updates included.
AI Summary
AIxCrypto Holdings, Inc. (formerly Qualigen Therapeutics, Inc. and RITTER PHARMACEUTICALS INC) filed an 8-K on November 21, 2025, reporting events as of November 20, 2025. The filing indicates the company is in the Pharmaceutical Preparations sector (SIC 2834) and is incorporated in Delaware. The report details financial statements and exhibits, along with other events and a Regulation FD disclosure.
Why It Matters
This 8-K filing provides an update on AIxCrypto Holdings, Inc.'s corporate activities and financial reporting, which is crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial statements and other events, without any immediate indication of significant negative developments.
Key Players & Entities
- AIxCrypto Holdings, Inc. (company) — Registrant
- Qualigen Therapeutics, Inc. (company) — Former company name
- RITTER PHARMACEUTICALS INC (company) — Former company name
- November 20, 2025 (date) — Earliest event date
- November 21, 2025 (date) — Filing date
- 2834 (industry_code) — Standard Industrial Classification (SIC)
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific 'Other Events' are disclosed in this 8-K filing?
The filing indicates 'Other Events' are reported, but the specific details of these events are not provided in the excerpt. Further review of the full document is required.
What is the Standard Industrial Classification (SIC) code for AIxCrypto Holdings, Inc. and what does it represent?
The SIC code is 2834, which corresponds to 'Pharmaceutical Preparations'.
When was AIxCrypto Holdings, Inc. formerly known as Qualigen Therapeutics, Inc. and RITTER PHARMACEUTICALS INC?
The company was formerly known as Qualigen Therapeutics, Inc. after changing from RITTER PHARMACEUTICALS INC on May 26, 2020.
What is the principal executive office address for AIxCrypto Holdings, Inc.?
The principal executive offices are located at 5857 Owens Avenue, Suite 300, Carlsbad, California 92008.
What is the filing date and the earliest event date reported in this 8-K?
The filing date is November 21, 2025, and the earliest event date reported is November 20, 2025.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-11-21 16:23:28
Key Financial Figures
- $0.001 — ch registered Common stock (par value $0.001 per share) QLGN The Nasdaq Stock Ma
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 37KB
- ex-99_001.jpg (GRAPHIC) — 177KB
- ex-99_002.jpg (GRAPHIC) — 127KB
- ex-99_003.jpg (GRAPHIC) — 125KB
- 0001493152-25-024639.txt ( ) — 835KB
- qlgn-20251120.xsd (EX-101.SCH) — 3KB
- qlgn-20251120_lab.xml (EX-101.LAB) — 33KB
- qlgn-20251120_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 20, 2025 AIxCRYPTO HOLDINGS, INC. By: /s/ Kevin A. Richardson II Name: Kevin A. Richardson II Title: Co-Chief Executive Officer